Aus coViki
Wechseln zu: Navigation, Suche


  • GET ä. Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks? Extract
  • GET ä. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design Extract
  • GET 2020. Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS) Extract
  • GET 2020. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis Extract
  • GET 2020. Why not to use colchicine in COVID-19? An old anti-inflammatory drug for a novel auto-inflammatory disease. Extract
  • GET 2020. Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19? Extract
  • GET 2020. Colchicine and COVID-19. Extract
  • GET 2020. COVID-19 infection in a patient with FMF: does colchicine have a protective effect? Extract
  • GET 2020. Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial. Extract
  • GET 2020. Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak. Extract
  • GET 2020. Colchicina: una herramienta terapeutica potencial frente a COVID-19. Experiencia en 5 pacientes. Extract
  • GET 2020. Colchicin Treatment of Covid-19 Presenting With Cutaneous Rash and Myopericarditis. Extract
  • GET 2020. Treating COVID-19 with colchicine in community healthcare setting. Extract
  • GET 2020. The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al. Extract
  • GET 2020. Comment on "Colchicine may not be effective in COVID-19 infection; it may even be harmful?" Extract
  • GET 2020. Colchicine as a possible therapeutic option in COVID-19 infection. Extract
  • GET 2020. Colchicine may not be effective in COVID-19 infection; it may even be harmful? Extract
  • GET 2020. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. Extract
  • GET 2020. Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)-An Old Drug With New Life? Extract


GET 2020. Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19. Extract
  • GET 2020. Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19. Extract
Meine Werkzeuge